Insider Trading & Ownership - Trieu Vuong

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Trieu Vuong
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-11-22
Purchase
2024-11-26
11:33 am
Oncotelic Therapeutics Inc.OTLCTrieu Vuong
CHAIRMAN AND CEO
10% Owner
298,499$0.0289$8,627116,495,629
(Indirect
Direct)
View
2024-08-23
Purchase
2024-08-27
08:00 am
Oncotelic Therapeutics Inc.OTLCTrieu Vuong
CHAIRMAN AND CEO
10% Owner
500,000$0.02$10,000116,197,130
(Indirect
Direct)
View
2023-06-28
Purchase
2023-06-30
09:25 am
Oncotelic Therapeutics Inc.OTLCTrieu Vuong
CHAIRMAN AND CEO
10% Owner
500,000$0.02175$10,875115,272,130
(Indirect
Direct)
View
2023-06-16
Purchase
2023-06-20
12:00 pm
Oncotelic Therapeutics Inc.OTLCTrieu Vuong
CHAIRMAN AND CEO
10% Owner
100,000$0.026$2,600115,197,130
(Indirect
Direct)
View
2023-06-14
Purchase
2023-06-16
12:00 pm
Oncotelic Therapeutics Inc.OTLCTrieu Vuong
CHAIRMAN AND CEO
10% Owner
400,000$0.0326$13,040115,097,130
(Indirect
Direct)
View
2023-05-26
Purchase
2023-05-31
09:39 am
Oncotelic Therapeutics Inc.OTLCTrieu Vuong
CHAIRMAN AND CEO
10% Owner
126,888$0.0341$4,327114,697,130
(Indirect
Direct)
View
2023-05-02
Purchase
2023-05-02
5:00 pm
Oncotelic Therapeutics Inc.OTLCTrieu Vuong
CHAIRMAN AND CEO
10% Owner
100,000$0.045$4,500114,570,242
(Indirect
Direct)
View
2022-12-06
Purchase
2022-12-07
08:00 am
Oncotelic Therapeutics Inc.OTLCTrieu Vuong
CHAIRMAN AND CEO
10% Owner
120,000$0.05$6,000114,210,934
(Indirect
Direct)
View
2022-11-22
Purchase
2022-11-25
09:00 am
Oncotelic Therapeutics Inc.OTLCTrieu Vuong
CHAIRMAN AND CEO
10% Owner
70,000$0.08$5,600114,090,934
(Indirect
Direct)
View
2022-09-26
Purchase
2022-09-28
09:15 am
Oncotelic Therapeutics Inc.OTLCTrieu Vuong
CHAIRMAN AND CEO
10% Owner
20,000$0.068$1,360114,020,934
(Indirect
Direct)
View
2022-08-25
Purchase
2022-08-29
09:15 am
Oncotelic Therapeutics Inc.OTLCTrieu Vuong
CHAIRMAN AND CEO
10% Owner
80,000$0.082$6,560114,000,934
(Indirect
Direct)
View
2020-11-19
Purchase
2020-11-23
3:01 pm
MATEON THERAPEUTICS INCMATNTrieu Vuong
CHIEF EXECUTIVE OFFICER
50,500$0.19$9,59519,944,035
(Indirect
Direct)
View
2020-03-26
Purchase
2020-03-27
5:49 pm
MATEON THERAPEUTICS INCMATNTrieu Vuong
CHIEF EXECUTIVE OFFICER
3,000$0.12$36019,893,535
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-09-03
Option Award
2021-09-08
5:00 pm
N/A
2031-09-03
Oncotelic Therapeutics Inc.OTLCTrieu Vuong
Chief Executive Officer
225,000$0225,000
(Direct)
View
2021-03-31
Conversion
2021-07-16
5:38 pm
N/A
N/A
Oncotelic Therapeutics Inc.OTLCTrieu Vuong
CHAIRMAN AND CEO
10% Owner
94,070,882$097,913,805
(Direct)
View
2021-07-08
Option Award
2021-07-16
5:38 pm
2021-07-08
2031-07-08
Oncotelic Therapeutics Inc.OTLCTrieu Vuong
CHAIRMAN AND CEO
10% Owner
773,255$097,913,805
(Direct)
View